John Stagg

Affiliation : Université de Montréal
Organization : CR-CHUM
E-mail :
Web site

About John Stagg

John Stagg obtained his Ph.D. in experimental medicine in 2005 from McGill University. He then completed a postdoctoral fellowship in 2010 in cancer immunology at the Peter MacCallum Cancer Centre in Melbourne. During his postdoctoral fellowship, he identified CD73, a membrane enzyme responsible for extracellular adenosine production, as a novel therapeutic target for cancer immunotherapy. He also participated in the development of anti-CD73 antibodies and adenosine inhibitors now in clinical trials. His lab investigates mechanisms of resistance to cancer immunotherapy and develops novel immune-stimulating therapeutic strategies. John Stagg holds a CIHR New Investigator Award and the Jean-Guy Sabourin Research Chair in Pharmacology from Université de Montréal.

Ongoing competitions